SCHEMBL4792964

SCHEMBL4792964

FC1(F)CCC(C[AsH2])CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL580930 0.74 APLNR (0.32) APLNR
SCHEMBL1983555 0.72 APLNR (0.31) APLNR
SCHEMBL22906 0.72 APLNR (0.31) APLNR
SCHEMBL16911410 0.72 APLNR (0.31) APLNR
SCHEMBL16499990 0.72 APLNR (0.31) APLNR
SCHEMBL102863 0.72 NCF1 (0.39) APLNR
SCHEMBL22907 0.72 APLNR (0.55) APLNR
SCHEMBL178339 0.72 KDM4E (0.42) APLNR
SCHEMBL3941149 0.71
Hydrochloric Acid SCHEMBL306682 0.70 NCF1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001876-A2 8-AZABICYCLOÝ3.2.1¨OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-12-17 EP disclosed
WO-2007103187-A2 8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2007-09-13 WO disclosed